PRESENTATION
Q4 2024 — Earnings presentation
Q4 2024PDF · 19 pages10.7 MB
Championing a Smoke-Free World 2024 Fourth-Quarter and Full-Year Results February 6, 2025 Introduction • A glossary of terms as well as adjustments, other calculations and reconciliations to the most directly comparable U.S. GAAP measures for non-GAAP financial measures cited in this presentation are available in Exhibit 99.2 to the company's Form 8-K dated February 6, 2025 and on our Investor Relations website with additional non- GAAP reconciliations available at the end of this presentation 2 -- 1 of 19 -- Forward-Looking and Cautionary Statements • This presentation contains projections of future results and goals and other forward-looking statements, including statements regarding expected financial or operational performance; capital allocation plans; investment strategies; market expectations; regulatory outcomes; sustainability plans and projections; business plans and strategies; and dividends. Achievement of future results is subject to risks, uncertainties and inaccurate assumptions. In the event that risks or uncertainties materialize, or underlying assumptions prove inaccurate, actual results could vary materially from those contained in such forward-looking statements. Pursuant to the “safe harbor” provisions of the Private Securities Litigation Reform Act of 1995, PMI is identifying important factors that, individually or in the aggregate, could cause actual results and outcomes to differ materially from those contained in any forward-looking statements made by PMI • PMI's business risks include: excise tax increases and discriminatory tax structures; increasing marketing and regulatory restrictions that could reduce our competitiveness, eliminate our ability to communicate with adult consumers, or ban certain of our products in certain markets or countries; health concerns relating to the use of tobacco and other nicotine-containing products and exposure to environmental tobacco smoke; litigation related to tobacco and / or nicotine use and intellectual property; intense competition; the effects of global and individual country economic, regulatory and political developments, natural disasters and conflicts; the impact and consequences of Russia's invasion of Ukraine; changes in adult smoker behavior; the impact of natural disasters and pandemics on PMI's business; lost revenues as a result of counterfeiting, contraband and cross-border purchases; governmental investigations; unfavorable currency exchange rates and currency devaluations, and limitations on the ability to repatriate funds; adverse changes in applicable corporate tax laws; adverse changes in the cost, availability, and quality of tobacco and other agricultural products and raw materials, as well as components and materials for our electronic devices; and the integrity of its information systems and effectiveness of its data privacy policies. PMI's future profitability may also be adversely affected should it be unsuccessful in its attempts to introduce, commercialize, and grow smoke-free products or if regulation or taxation do not differentiate between such products and cigarettes; if it is unable to successfully introduce new products, promote brand equity, enter new markets or improve its margins through increased prices and productivity gains; if it is unable to expand its brand portfolio internally or through acquisitions and the development of strategic business relationships; if it is unable to attract and retain the best global talent, including women or diverse candidates; or if it is unable to successfully integrate and realize the expected benefits from recent transactions and acquisitions. Future results are also subject to the lower predictability of our smoke-free business’ performance • PMI is further subject to other risks detailed from time to time in its publicly filed documents, including PMI’s Annual Report on Form 10-K for the fourth quarter and year ended December 31, 2023 and the Form 10-Q for the quarter ended September 30, 2024, and the Form 10-K for the fourth quarter and year ended December 31, 2024 which will be filed today. PMI cautions that the foregoing list of important factors is not a complete discussion of all potential risks and uncertainties. PMI does not undertake to update any forward-looking statement that it may make from time to time, except in the normal course of its public disclosure obligations • References to “PMI”, “we”, “our” and “us” mean Philip Morris International Inc, including its subsidiaries 3 2024: Outstanding Year for Smoke-Free Transformation • Very strong organic top and bottom-line growth across all categories: ⎼ Fourth consecutive year of total volume growth ⎼ Continued IQOS growth momentum, increasing profitability ⎼ ZYN sequential volume acceleration ⎼ Strong combustible net revenue & profit growth ⎼ +15% organic OI growth, +10% in USD • +9% USD Adj. diluted EPS growth, mitigating currency headwinds with price and cost actions • Strong cashflow generation and deleveraging 4 Source: PMI Financials or estimates -- 2 of 19 -- 10 Years of Smoke-Free Transformation 2024 Key Milestones 5 • Nearly $15bn smoke-free net revenues, >$10bn total PMI adj. net earnings (a) • Smoke-free net revenues 40% of total PMI in Q4, ~60% in Top-5 OI markets (b) • Multi-category strategy deployed in ~50% of 95 smoke-free markets, >38.5m users • >1bn oral smoke-free product(c) cans (644m nicotine pouch cans) • FDA authorization for all ZYN products currently marketed by Swedish Match in the U.S. (a) Adjusted net earnings attributable to PMI. (b) Ranking based on FY’24 OI (c) Excluding snuff, snuff leaf and U.S. chew. Source: PMI Financials or estimates Adj. Smoke-Free Net Revenues ($ billion) 0.2 0.9 3.8 4.2 5.7 6.9 9.3 10.2 12.814.7 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 Note: Growth rates presented on an organic basis reflect currency-neutral adjusted results, excluding acquisitions. Shipment volume includes HTUs, cigarettes and oral SFPs excluding snuff, snuff leaf and U.S. chew. Source: PMI Financials or estimates FY24: Very Good Growth Across Key Metrics 6 Organic Adj. incl. Curr. & Acq. Operating Cashflow $12.2 bn Adj. Diluted EPS +15.6 % +9.3% $6.57 Operating Income +14.9 % +10.1% $14.7 bn Shipment Volume +2.9 % 774 bn Net Revenues +7.4% +9.8 % $37.9 bn FY’24 vs. PY (Adjusted) (Adjusted) FY’24 (Curr. neutral) -- 3 of 19 -- Adj. Diluted EPS (Variance vs. PY) Operating Income (Variance vs. PY) Net Revenues (Variance vs. PY) Shipment Volume (Variance vs. PY) Note: Growth rates presented on an organic basis reflect currency-neutral adjusted results, excluding acquisitions. Shipment volume includes HTUs, cigarettes and oral SFPs excluding snuff, snuff leaf and U.S. chew. Source: PMI Financials or estimates Q4: Very Good Growth Across Key Metrics 7 Organic Adj. incl. Curr. & Acq. +9.6 % +14.0% +11.8 % +15.3% +7.3% +2.3 % Q4’24 +7.3 % (Curr. neutral) Strong Top-line Momentum, Accelerating Profit Growth 8 Note: Chart not to scale. Growth rates presented on an organic basis reflect currency-neutral adjusted results, excluding acquisitions. Source: PMI Financials or estimates 15.4% 10.1% 11.0% 15.6% 2021 2022 2023 2024 Adj. Diluted EPS Growth (Currency neutral vs. PY) Net Revenue Growth (Organic vs. PY) 7.6% 7.1% 7.8% 9.8% 2021 2022 2023 2024 -- 4 of 19 -- Accelerated Smoke-Free & Combustibles Performance 9 (a) Represents Smoke-Free Business. Note: Organic gross margin growth is calculated based on organic gross profit, divided by organic net revenues. Chart not to scale. Growth rates presented on an organic basis reflect currency-neutral adjusted results, excluding acquisitions. Source: PMI Financials or estimates Net Revenues Gross Profit Operating Income 12.7% 9.8% Total PMI Net Revenues Gross Profit 22.7% Smoke-Free(a) Combustibles FY’24 Organic Growth vs. PY Net Revenues Gross Profit 14.9% 16.7% +330bps Smoke-Free Gross Margin 5.9% 6.8% +60bps Combustible Gross Margin ~$10bn Gross Profit FY’24 (a) Volumes shown in pouch or pouch equivalents, excluding snuff, snuff leaf and U.S. chew Note: Total SFP volumes represent HTUs, Oral SFPs and VEEV volumes in equivalent units. Total may not foot due to rounding. Source: PMI Financials or estimates Fourth Consecutive Year of Volume Growth 10 (shipments in bn units; change vs. PY) 612.9 125.3 14.0 Total 752.2 Oral SFP(a) HTUs Cigarettes 2.9% 11.6% 0.6% 24.6% 12.6% 0.8% Shipments Adj. IMS 774.0 616.8 139.7 17.4 24.5% 3.1% 1.7bn 2.7x vs. PY VEEV Shipments Total SFP Shipments +13.5% 2023 2024 FY’24 vs. PY incl. VEEV -- 5 of 19 -- FY'24 Organic Shipment Volume Organic Net Revenue Growth FY'24 Adj. Net Revenue Growth 7.4% Pricing (Combustibles & Smoke-Free(a)) 9.8% Currency & Acquisitions Top-Line Growth Powered by Volumes, Pricing & Category Mix 11 (a) Represents Smoke-Free Business. Note: Smoke-free mix represents the impact of an increased proportion of smoke-free products at higher net-revenue per unit and is calculated at total PMI level, excluding the impact from market mix. Total may not foot due to rounding. Source: PMI Financials or estimates 2.9% +1.9pp +6.2pp Smoke-Free Mix Impact (2.4)pp (1.2)pp Geographic Mix & Other 2.2pp Oral SFP FY'23 FY'24 SG&A Gross Margin 39.6% Currency & Acquisitions OI Margin Expansion While Investing For Growth 12 Note: Total may not foot due to rounding. Source: PMI Financials or estimates 37.8% FY’24 Adjusted OI Margin 38.8% +1.6pp +0.2pp (0.8)pp FY’24 (excl. Curr. & Acq.) +180bps +100bps -- 6 of 19 -- 20.6 21.7 23.7 25.1 27.4 28.8 30.7 32.2 4.2 5.2 5.7 0.5 0.8 1.0 33.3 36.3 38.6 H1'21 FY'21 H1'22 FY'22 H1'23 FY'23 H1'24 FY'24 (a) See Glossary for definition. (b) Total Smoke-Free Product Users are net of estimated poly-users across categories. Note: periods up until H1’23 include only IQOS and exclude Swedish Match in FY’22 and H1’23. Source: PMI Financials or estimates and PMI Market Research Over 38m Users of PMI Smoke-Free Products 13 Total Smoke-Free Product Users(a) (in millions) Estimated users who have switched to IQOS and stopped smoking(a) 72% 71% 71% 73% 73% 71% 72% IQOS Oral SFP E-Vapor Total Users(b) 72% +5.3m vs.PY Continued IQOS HTU Momentum, Accelerating Profitability 14 IQOS Product Contribution(a) (Indexed, 2020 =100) Note: HTU Adj. IMS in 2020 and 2021 represent reported IMS. (a) At constant exchange rates. Product contribution calculated as gross profit minus commercial and R&D costs. Source: PMI Financials or estimates 76 92 105 121 136 2020 2021 2022 2023 2024 HTU Adj. IMS (billion units) 100 215 246 299 366 2020 2021 2022 2023 2024 +15bn Average 2020-24 (incl. new markets) -- 7 of 19 -- 11.1 11.6 12.0 12.4 12.6 12.9 13.2 13.5 9.2% 9.0% 8.7% 9.7% 10.2% 9.8% 9.5% 10.6% Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 (a) Based on a four-quarter moving average. Source: PMI Financials or estimates Europe: Broadening Growth Drivers, Underlying Momentum 15 Adj. IMS(a) (in billion units) 2023 +9.4% FY’24 vs. PY Adj. IMS HTU Adj. SoM 2024 Impressive Progress in European Key Cities 16 Source: PMI Financials or estimates 7.0% 7.9% 9.0% 9.6% 9.9% 12.0% 17.7% 18.8% 19.5% 21.7% 21.8% 27.2% 28.8% 30.1% 32.9% 40.7% Stockholm Amsterdam Madrid Vienna London Munich Sofia Zurich Bucharest Warsaw Prague Lisbon Bratislava Rome Athens Budapest +1.2pp +1.9pp +1.2pp +2.8pp (0.2)pp PMI HTU Offtake Share (Q4’24) (0.6)pp Change vs. PY +0.2pp +2.1pp +1.9pp +2.9pp +3.4pp +3.0pp +3.5pp +1.6pp +1.3pp +1.2pp -- 8 of 19 -- 9.0 9.3 9.6 9.9 10.2 10.5 10.9 11.2 Japan: Continued Excellent IQOS Performance 17 26.2% 26.3% 26.5% 27.5% 29.2% 29.4% 29.9% 30.6% Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Adj. IMS(a) (in billion units) Japan HTU Offtake Share(b) Q4’23 Q4’24 Sendai +2.4pp 32.1% 34.5% Tokyo 34.1% 36.3% +2.2pp Fukuoka +3.2pp 30.9% 34.1% 2023 (a) Based on a four-quarter moving average. (b) Based on 3 C-Store Chains offtake. Base includes cigarettes, cigarillos and HTUs. Source: PMI Financials or estimates +13.2% FY’24 vs. PY Adj. IMS HTU Adj. SoM 2024 Sendai Tokyo Fukuoka 56.4% 51.7% Nagoya 49.8% Sapporo 49.3% Saitama Kumamoto 52.0% Chiba Kawasaki 52.8% 53.6% 52.3% 52.0% Yokohama 51.2% Hamamatsu 50.7% Shizuoka 50.6% Category Penetration Surpassing 50% In Multiple Key Cities 18 (a) Based on 3 C-Store Chains offtake. Base includes cigarettes, cigarillos and HTUs Source: PMI Financials or estimates Dec’24 Offtake HnB Category Share(a) 47.1% National +4.1pp vs. PY +2 cities vs. Sep’24 -- 9 of 19 -- 19 2.9% 4.0% 4.2% 4.3% 4.4% 4.5% 4.7% 5.3% 8.8% 12.9% 13.3% 15.6% 16.1% 18.9% Toronto Mexico City Manila Tunis Bogota Riyadh Rabat Urban Jakarta Cairo Kuala Lumpur Seoul Belgrade Duty Free (Airports) Podgorica +2.6pp +1.8pp (0.6)pp PMI HTU Offtake Shares (Q4’24) +2.0pp Change vs. PY +1.1pp +3.1pp +3.4pp +0.5pp +1.2pp (a) Duty Free includes airports where IQOS is available, offtake share based on Sep-Nov’24 vs. Sep-Nov’23. Note: Urban Jakarta represents West, Central and South Jakarta which include an estimated 1.5 million Legal Age Nicotine Users. Cairo represents Urban Cairo, Manila represents Metro Manila, Tunis represents Greater Tunis. Source: PMI Financials or estimates +1.0pp Strong Key City Growth Across Global Markets +0.6pp +1.3pp +1.1pp +3.2pp (a) U.S. IQOS ‘Be The First’ Campaign Continues 20 -- 10 of 19 -- 50 59 64 65 73 90 105 116 132 135 149 165 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Source: PMI Financials or estimates, Circana, LLC, Nicotine Pouches, Week ending 12/29/24 Strong ZYN Demand, Sequential Volume Acceleration 21 U.S. Nicotine Pouch Category Volume Share (4-week period, %) 2024 2023 Q1 Q2 Q3 Q4 Q1 Q2 2022 ZYN U.S. Shipment Volumes (million cans) Q3 66.5% 73.2% 64.7% 65.5% 65.9% 18.8% 7.1% 3.5% 0% 5% 10% 15% 20% 25% 30% 35% 40% 45% 50% 55% 60% 65% 70% 75% 72.4% ZYN Retail Value Share Q4’24 (13-week period) ZYN Competitor 1 Competitor 2 Competitor 3 2023 2024 Q4 ZYN Leading Category Growth Again Despite Constraints 22 Source: PMI Financials or estimates, Circana, LLC, Nicotine Pouches, Week ending 12/29/24 ZYN and U.S. Nicotine Pouch Category (Offtake sequential volume change, %) 11% 20% 17% 16% 17% -3% 1% 9% 10% 18% 12% 13% 15% 5% 6% 7% Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 2023 ZYN U.S. Nicotine Pouch Category 2024 • Category trends driven by ZYN • Stronger demand limits progress in retail availability: ⎼ Production capacity continues to grow ⎼ Target full normalization in H2’25 • Well-positioned for strong growth • First and only FDA-authorized nicotine pouch brand -- 11 of 19 -- (a) Markets where PMI commercializes nicotine pouches, including U.S. Source: PMI Financials or estimates Increasing Growth Contribution from ZYN Internationally 23 9.6 Q4'24 37 Global Markets(a) International Nicotine Pouch Shipment Volumes (growth vs. PY, million cans) 27.2 FY'24 +75% vs. PY +9 Q4’24 vs. PY (a) Based on Sep-Nov’24 offtake volumes. (b) Italy and Czech Republic based on Nielsen, Italy including tobacco shops only. France based on Strator. Source: PMI Financials or estimates Very Good VEEV Traction in Key Geographies 24 Italy 100 267 Q4'23 Q4'24 Czech Republic • Increasingly contributing to multi- category offer, generating incremental growth • Top-3 pod brand in 13 European markets(a): VEEV ONE Offtake Volumes(b) (Indexed, Q4’23 =100) 100 249 Q4'23 Q4'24 France 100 278 Q4'23 Q4'24 Belgium Czech Rep. Estonia Finland France Germany Greece Italy Poland Portugal Romania Slovakia 1 st 1 st 1 st 1 st 1 st Bulgaria -- 12 of 19 -- Combustibles: Strong Pricing & Efficiencies Drive Profitability 25 (a) Pricing variance is based on adjusted net revenues. Source: PMI Financials or estimates 2.7 5.0 8.9 8.7 2021 2022 2023 2024 Combustible Pricing (% organic growth vs. PY)(a) • Growing total industry, essentially driven by markets where SFPs are banned: ⎼ Secular declines persist elsewhere • Maximizing value with pricing and cost efficiencies • Strong performance from Marlboro and global brands Combustible Gross Profit (% organic growth vs. PY) 0.5 1.9 0.3 6.8 2021 2022 2023 2024 (a) Includes cigarettes and SFP volumes. (b) Includes HTUs, e-vapor unit equivalents and oral SFP in pouch or pouch equivalents, excluding snuff, snuff leaf and U.S. chew. (c) On an organic basis. (d) Currency neutral variance. (e) At prevailing rates. Source: PMI Financials or estimates 2025: Another Year of Superior Growth Expected • Adjusted diluted EPS forecast of $7.04 -7.17 incl. unfavorable currency impact of 22 cents(e) ⎼ Includes Q1 forecast of $1.58-1.63 with 4 cents of unfavorable currency(e) 26 2025 Outlook Up to 2% Total Shipment Volumes(a) 12-14 % SFP Shipment Volumes(b) 10-12 % HTU Adj. IMS Growth 780-820 m U.S. ZYN Shipment Volumes, (cans) 6-8 % Net Revenue Growth(c) 10.5-12.5 % Adj. OI Growth (c) 10.5-12.5 % Adj. Diluted EPS Growth(d) 7-9 % Adj. Diluted EPS Growth, USD(e) -- 13 of 19 -- Adj. Diluted EPS (Currency Neutral Variance vs. PY) Operating Income (Variance vs. PY) Net Revenues (Variance vs. PY) Shipment Volume (Variance vs. PY) Note: Growth rates presented on an organic basis reflect currency-neutral adjusted results, excluding acquisitions/divestitures. Shipment volume for 2024 and 24-26 CAGR targets includes HTUs, cigarettes and oral SFPs excluding snuff, snuff leaf and U.S. chew. 2025 forecast also includes e-vapor. (a) At 2023 corporate income tax rates. Source: PMI Financials or estimates Delivering Best-in-Class CPG Performance 27 +15.6% +14.9% +9.8% +2.9% FY’24 Organic 2024-26 CAGR Targets +9-11%(a) +8-10% +6-8% Positive Organic +10.5-12.5% +10.5-12.5% +6-8% Up to 2% 2025 Forecast Organic (a) As of December 31, on a 12-month rolling basis. (b) At prevailing rates, subject to year-end working capital requirements. Note: Operating cash flow is defined as net cash provided by operating activities. Source: PMI Financials or estimates Highly Cash Generative With Focus on Deleveraging 28 Net Debt to Adjusted EBITDA Ratio(a) 2.04 1.91 1.93 1.62 2.89 3.16 2.66 2018 2019 2020 2021 2022 2023 2024 • Expect strong 2025 operating cash flow of ~$11bn, broadly in line with 2024 before non-recurring tax and Germany payments(b) • Investing in innovation and growth: ⎼ Capital expenditures of around $1.5 billion • Unwavering commitment to progressive dividend • Continue to target ~2.0x net debt to adjusted EBITDA by end of 2026, with further improvement in 2025 -- 14 of 19 -- Outstanding 2024 Delivery, Very Strong 2025 Expected 29 • Powerful combination of underlying momentum and proactive steps supports best-in-class growth profile: ⎼ Structural smoke-free top-line growth with superior economics ⎼ Investing for growth while driving profitability through mix, pricing, scale and efficiencies • Smoke-free transformation delivering meaningful value for shareholders: ⎼ Broad-based performance drives cash generation ⎼ 17y of dividend growth, committed to shareholder returns Source: PMI Financials or estimates Championing a Smoke-Free World Questions & Answers iOS Download Android Download Have you downloaded the PMI Investor Relations App? The free IR App is available to download at the Apple App Store for iOS devices and at Google Play for Android mobile devices Or go to: www.pmi.com/irapp 2024 Fourth-Quarter and Full-Year Results -- 15 of 19 -- Championing a Smoke-Free World 2024 Fourth-Quarter and Full-Year Results February 6, 2025 Championing a Smoke-Free World 32 Appendix and Reconciliation of Non-GAAP Measures -- 16 of 19 -- Approximate Impact of Currency on 2024 EPS 33 Source: PMI Financials or estimates FY 2024 $(0.19) Japanese Yen $(0.14) Egyptian Pound $(0.07) Russian Ruble $(0.04) Euro $0.18 Argentine Peso $(0.12) Others $(0.38) Total PMI Currency Impact ($/share) (a) See forecast assumptions in Earnings Release for details Source: PMI Financials or estimates 2025: EPS Guidance Growth 2024 2025 Forecast $4.52 $6.55 – $6.68 Reported Diluted EPS Adjustments: 0.10 - - Restructuring charges 0.01 - - Impairment of goodwill and other intangibles 0.40 0.49 - Amortization of Intangibles(a) 0.13 - - Loss on sale of Vectura Group 0.03 - - Egypt sales tax charge 0.05 - - Megapolis localization tax impact 0.14 - - Income tax impact associated with Swedish Match AB financing 1.49 - - Impairment related to the RBH equity investment (0.27) - - Fair value adjustment for equity security investments (0.03) - - Tax items 2.05 0.49 - Total Adjustments 7.2% – 9.1% $6.57 $7.04 – $7.17 Adjusted Diluted EPS (0.22) - Less: Currency 10.5% –12.5% $6.57 $7.26 – $7.39 Adjusted Diluted EPS, excluding currency 34 Full-Year ($/share) -- 17 of 19 -- Select European Markets: PMI HTU Adjusted Share of Market Change vs. PY FY’24 Change vs. PY FY’24 Change vs. PY FY’24 +1.2pp 17.2% Slovak Republic +0.1pp 16.9% Italy +1.2pp 8.3% Austria +2.0 14.3 Slovenia +0.3 28.1 Lithuania - 14.9 Czech Republic +0.5 2.8 Spain +0.1 9.1 Poland +0.9 6.2 Germany +1.3 12.8 Switzerland +2.4 20.6 Portugal +2.3 21.8 Greece +1.1 4.6 United Kingdom +1.1 8.9 Romania +3.4 32.3 Hungary 35 Source: PMI Financials or estimates 36 PHILIP MORRIS INTERNATIONAL INC. and Subsidiaries Reconciliation of Non-GAAP Measures Reconciliation of Net Earnings attributable to PMI to Adjusted Net Earnings attributable to PMI ($ in millions) / (Unaudited) (a) Represents adjustments impacting 2023 only: South Korea indirect tax charge ($174 million), Termination of agreement with Foundation for a Smoke-Free World ($111 million), Termination of distribution arrangement in the Middle East ($70 million), Charges related to the war in Ukraine ($43 million), and Swedish Match AB acquisition accounting related items ($13 million). Source: PMI Financials or estimates Net Earnings attributable to PMI $ 7,057 $ 7,813 (9.7)% (2.2)% (756) (594) 9 2,203 764 (3,138) Restructuring charges (150) (96) (56.3)% (56.3)% (54) - - - - (54) Impairment of goodwill and other intangibles (20) (678) 97.1% 97.1% 658 - - - - 658 Amortization of intangibles (629) (389) (61.7)% (61.7)% (240) - - - - (240) Megaplis localization tax impact (77) - - - (77) - - - - (77) Income tax impact associated with Swedish Match AB financing (209) 170 -(100)% -(100)% (379) - - - - (379) Egypt sales tax charge (39) - - - (39) - - - - (39) Loss on sale of Vectura Group (206) - - - (206) - - - - (206) Impairment related to the RBH equity investment (2,316) - - - (2,316) - - - - (2,316) FV Adjustment for equity security investments 418 38 +100% +100% 380 - - - - 380 Tax items 47 (173) +100% +100% 220 - - - - 220 Other adjustments impacting 2023 only (a) - (411) +100% +100% 411 - - - - 411 Adjusted Net Earnings attributable to PMI $ 10,238 $ 9,352 9.5% 15.7% 886 (594) 9 2,203 764 (1,496) Price Vol/ Mix Cost/ Other Years ended December 31, Change Fav./(Unfav.) Variance Fav./(Unfav.) 2024 2023 Total Excl. Curr. & Acquis. Total Currency Acquisitions -- 18 of 19 -- Championing a Smoke-Free World 2024 Fourth-Quarter and Full-Year Results February 6, 2025 -- 19 of 19 --